background preloader

Via:packrati.us 34

Facebook Twitter

SVN

NCI Cancer Bulletin for June 29, 2010. Name of the Trial A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-resistant Prostate Cancer (NCI-09-C-0195). See the protocol summary . Dr. William Dahut Principal Investigator Dr. Why This Trial Is Important Men with advanced prostate cancer often receive treatment to block the production of androgens , which are male sex hormones that may help prostate tumors grow. NCI Cancer Bulletin for June 29, 2010. Gefitinib Improves Progression-free Survival for Metastatic Lung Cancers with EGFR Mutations Patients newly diagnosed with metastatic non-small cell lung cancer (NSCLC) who received gefitinib (Iressa) had significantly higher response rates and longer progression-free survival compared with patients who received carboplatin plus paclitaxel (73.7 percent versus 30.7 percent and 10.8 months versus 5.4 months, respectively), according to results of a phase III trial conducted in Japan.

The results were published in the June 24 New England Journal of Medicine . All patients enrolled in the study had epidermal growth factor receptor (EGFR) mutations that were sensitive to the tyrosine kinase inhibitor (TKI) gefitinib. The patients did not have the resistant EGFR mutation T790M, and they had not been previously treated with chemotherapy. The researchers, led by Dr. Study Finds Poor Physician Adherence to Cervical Cancer Screening Guidelines. New developments in pancreatic cancer @AACR - Pharma Strategy Blog. Pancreatic cancer is a devastating disease with a generally poor prognosis, largely because it is usually detected in late stage disease where chemotherapy options generally have a limited effect.

New developments in pancreatic cancer @AACR - Pharma Strategy Blog

Typically response rates with gemcitabine are around 5%, with advanced patients living around 5-6 months on average. Erlotinib, an EGFR inhibitor, is also approved in the USA for treatment of the disease, but the therapy only adds approximately two weeks to survival. Celgene buy Abraxis Bioscience for $2.9B - Pharma Strategy Blog. Childhood's Cures Haunted by Adulthood's 'Late Effects' NCI Cancer Bulletin for June 29, 2010. Gefitinib Improves Progression-free Survival for Metastatic Lung Cancers with EGFR Mutations Patients newly diagnosed with metastatic non-small cell lung cancer (NSCLC) who received gefitinib (Iressa) had significantly higher response rates and longer progression-free survival compared with patients who received carboplatin plus paclitaxel (73.7 percent versus 30.7 percent and 10.8 months versus 5.4 months, respectively), according to results of a phase III trial conducted in Japan.

The results were published in the June 24 New England Journal of Medicine . Obesity increases the risk of cancer death among Asians too. Historically, obesity has been a problem of western countries.

Obesity increases the risk of cancer death among Asians too

For instance, nearly 1 in 3 Americans is obese (defined as having a body mass index that tops 30), as are about 1 in 4 members of the United Kingdom. According to this ranking compiled with data from the Organization for Economic Cooperation and Development, the most obese countries in Asia are Japan and South Korea, where a mere 3.2% of the population has a BMI over 30. But with obesity rates rising in China, South Korea, Thailand, Singapore and other Asian countries, an international group of researchers wondered how those extra pounds might be raising the risk of death from cancer. After all, adding 5 points to one’s BMI is known to increase the risk of cancer among Caucasians by 10% to 60%. MELA's Stock Sale Suggests Problems for Skin Cancer Detector. Update: MELA Sciences priced 2.2 million shares of stock at $7.50 a share Wednesday.

MELA's Stock Sale Suggests Problems for Skin Cancer Detector

MELA expects to gross about $17.5 million, including the sale of over-allotment shares. MELA tried to get $8 a share for the stock offering Tuesday night, according to a source familiar with the deal terms. IRVINGTON, NY (TheStreet) -- MELA Sciences (MELA_) CEO Joseph Gulfo explained to investors on a Tuesday night conference call that the company decided to raise money now -- just two months shy of an all-important FDA advisory panel reviewing the company's melanoma skin cancer detection device -- because investors are worried that MELA is running short on cash. Celgene strikes $2.9B deal to acquire Abraxis. With an eye to burnishing its oncology rep and its already sizable revenue, Celgene has struck a deal to buy Abraxis BioScience for cash and stock totaling $2.9 billion.

Celgene strikes $2.9B deal to acquire Abraxis

The buyout gives Celgene control of Abraxane, now approved for breast cancer treatment, along with its discovery platform and a pipeline of experimental therapies. In exchange for every share of Abraxis, Celgene will pay $58 a share in cash and 0.2617 of a share of Celgene. That values Abraxis' shares at $71.93, a 17 percent bump on yesterday's close. Ethnic Supplies Ltd's Photos - Ethnic Supplies At BBC GWL. The Gov't Controls Google's Search Results for Your Brand. Surprised? Did you notice that lately, every time you search for a pharma brand on Google, the #1 organic result is always the NIH?

The Gov't Controls Google's Search Results for Your Brand. Surprised?

Always? Always. Celgene Acquires Abraxis for $2.9 Billion. SUMMIT, N.J.

Celgene Acquires Abraxis for $2.9 Billion

(TheStreet) -- Celgene (CELG_) is acquiring Abraxis BioScience (ABII) for $2.9 billion in cash and stock to expand its cancer drug business, the company announced Wednesday. Celgene is one of the largest biotech companies in the world, with revenue of $2.7 billion last year coming mainly from drugs like Revlimid used to treat cancers of the blood. By acquiring Abraxis, Celgene gains ownership of a drug used to treat breast cancer patients and expands the company's commercial operations into the solid tumor market. I'm Had Enough: Half of BC Survivors Stop Tamoxifen Early. 30 habits that will improve your life. Our worst habits are always the hardest ones to break, but if you can manage to insert at least a few of these positive habits into your daily routine, you’ll be ahead of the game.

30 habits that will improve your life

See a few below: Drink a glass of water when you wake up. Your body is dehydrated when you wake up, resolve that issue early and kickstart your day.Solve puzzles. Word games, sudoku, and quizzes are a great way to exercise your brain.Make quick decisions. Quick Financial Fixes - Forbes.com. How cognitive surplus will change the world: Clay Shirky - Pharma Strategy Blog. A Different Look at Community Management « Social Media Monitoring and Engagement – Radian6.

Community management isn’t what it used to be.

A Different Look at Community Management « Social Media Monitoring and Engagement – Radian6

Once upon a time, managing a community meant hanging out in an online location – be it a forum or a chat room – and moderating chat. Approving comments. Handling some support issues. Dealing with trolls, helping people with questions. That kind of thing. But community management, at least the way we approach it, isn’t just online issues management and discussion moderation anymore. Folks are sometimes surprised to learn about how large our team is, or how it’s structured, mostly because they’re thinking of community management as it’s always been.

Online Engagement. Finding pharma on your mobile device (early opportunities for exploration) Before looking at pharma companies testing out the mobile space, I want to introduce you to another healthcare organization that is diligently studying this channel.

Finding pharma on your mobile device (early opportunities for exploration)

A hospital system, you say? Nope. Insurance plan? Sorry. It's actually none other than the US government. At the Business Development Institute (BDI) Social Communications and Healthcare Conference last month, Centers for Disease Control and Prevention (CDC) Social Media Strategist Ann Aikin presented "Going Social 4 Health Impact," which you can view thanks to VEOMED. Last fall, the CDC invited Americans to opt in for text messages about a variety of health topics.

One key finding: 91% of participants surveyed said the text messages they received were easy to understand—a big win for the CDC's application of health literacy principles to a challenging medium. Chain of transplants gives 14 kidney patients new life. It started with a tragedy and ended with a priceless gift to 14 people. Jennifer Whitford, a 24-year-old mother of two from Sebring, Fla., died accidentally on May 24.

Her mother decided to donate her organs, and a national kidney registry found a perfectly matched recipient: Brenda Wolfe, 44, of Mount Airy, Md. Phil's Vacation: Day +5. Phil's Bone Marrow. 800,000 Strong Boycott BP Facebook Fan Page Mysteriously Vanishes. Porter Novelli unveils global service for brands experiencing social media crises. The agency’s ‘Real-Time Reputation Specialty’ offering aims to help clients by providing pre-emptive communications through to programmes that restore corporate reputation after an incident.

Porter Novelli unveils global service for brands experiencing social media crises

‘We’ve seen a lot of global organisations face unprecedented corporate communications challenges recently, which have brought a sharp focus on the importance of responding at the right time, in the right place, with the right tone,’ said Porter Novelli corporate practice leader Neil Bayley. ‘Think about Toyota, Eurostar, Nestlé and British Airways. Many Americans overtreated to death - Health - Cancer. UK scrambles to keep 'dozen eggs' in EU battle. 28 June 2010Last updated at 16:23 By Laurence Peter BBC News UK food producers are lobbying to retain labelling by numbers. Steve Woodruff - Yeah, this works...! - TwitVid. Gefitinib or Chemotherapy for Non–Small Cell Lung Cancer with Mutated EGFR - Pharma Strategy Blog. Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2 [Cell_Biology]

Early dinner, something tasty to go with it and then several. Eidogen-Sertanty. Warfarin For Early Cancer Detection? June 27th, 2010 by John Mandrola, M.D. in Better Health Network, Opinion, Research, True Stories In cancer treatment, detection of a tumor in an early stage markedly increases the chance of favorable outcomes. 2010 FIFA World Cup: No doping positives for 4th straight World Cup. Chicago Journals - The Journal of Infectious Diseases. + Author Affiliations Reprints or correspondence: Prof Hongxuan He, National Research Center for Wildlife Borne Diseases, Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, No. 1–5, Beichen West Rd, Chaoyang District, Beijing 100101, China (hehx@ioz.ac.cn).

Podcamp Boston 5! - PCB5- Eventbrite. Invalid quantity. Apple Nation. Share photos on Twitter. Eye on FDA: Clinical Trials and YouTube. Eye on FDA: Growing Use of Video Related to Clinical Trials. Inexpensive camera diagnoses cancer. Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits. Abstract Despite the recent rapid growth in genome-wide data, much of human variation remains entirely unexplained. A significant challenge in the pursuit of the genetic basis for variation in common human traits is the efficient, coordinated collection of genotype and phenotype data.

@blehr11 neither but this was yummy. A Grand Hyatt Stay « StickyFigure.